A study by the Syracuse University has revealed that regular exercise will help breast cancer survivors have better health. According to researchers, the adverse effect of hormonal drugs called Aromatase Inhibitors (AI) can be mitigated by aerobic and resistance physical workout.

Like Us on Facebook

The researchers subjected breast cancer survivors to a monitoring program where the effects of aerobic and resistance exercise on their bodies were examined. The physical activities performed include brisk walking, jogging, and weight training. The patients' percent of body fat, body mass index, bone mineral density, and lean body mass were also monitored.

A majority of the participants spent less than 55 minutes exercising every week. The researchers noted that many lifestyle-related factors affect the survivors' commitment to exercising. The co-author of the study Gwendolyn Thomas said that her team "noticed a drop in percent body fat and body mass index, as well as a significant increase in their lean body mass."

AIs help in preventing recurrence of the deadly disease, but it also halts the production of estrogen. Further, it was noted that the hormonal drug might cause severe joint pain and bones loss. Due to these adverse effects, roughly 40 percent of survivors tend to stop taking the drug even before the five-year long recommended-treatment ends.

Thomas said, "when women quit taking AIs, they increase the chances of their breast cancer recurring." She further explained that "if breast cancer survivors are obese or overweight, they are likely to experience arthralgia. Interventions that address obesity in women taking AIs can help them continue this necessary treatment."

The research team recommends that "exercise should be prescribed in conjunction with AIs, as part of a regular treatment regimen." Thomas also suggested that "by using a mobile platform for health promotion and behavior change, we can make exercise more accessible to breast cancer survivors, especially those who take inhibitors and struggle with obesity or being overweight."

The study, which was published in the Obesity Journal, received funding from the National Institute of Health.